2025 annual financial data
Autolus Therapeutics 2025 Operating margin
Direct answer
Operating margin was -372.45%.
Operating income was -281,437,148 USD and net income was -288,199,915 USD.
Operating cash flow was -283,568,000 USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 75,564,172 USD
- Operating income
- -281,437,148 USD
- Net income
- -288,199,915 USD
- Operating cash flow
- -283,568,000 USD